OTCQB: LXXGF | TSX.V: LXG
Learn more about the MiQLab solution offering in-clinic point-of-care veterinary diagnostic testing in ~2 hours addressing more than 50 percent of companion animal vet visits and increasing satisfaction.
LexaGene’s MiQLab has direct benefits for veterinary clinics. Using LexaGene’s proven point-of-care diagnostics for evidence-based treatment of common bacterial infections found in companion animals may also result in cost savings.
Pandemic containment in the United States has proved ineffective due to a lack of preparation and deployment of modern pathogen-detection technologies. Improved point-of-care molecular diagnostics will save lives when the next pandemic emerges.